Altimmune Q4 FY25 Earnings Results

https://misryoum.com/us/markets/altimmune-q4-fy25-earnings-results/

“ Altimmune reported a net loss of $27. Divyansh_Kasana · March 5, 2026 Altimmune reported a net loss of $27.4 million, or $0.27 per share, for the fourth quarter of 2025, compared to a net loss of $23.2 million,...

#Altimmune #FY25 #Earnings #Results #US_News_Hub #misryoum_com

By 2030, Bloomberg Intelligence estimates that global weight loss drug sales will top $93.8 Billion (US dollars). Incredible!!!

#EliLilly #Amgen #NovoNordisk #Viking #Altimmune #Structure #popularfitness